Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 2/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11616237 | 1.00 | ALDH1A1 (0.32) | ALDH1A1TDP1RECQLGLAHPGD | |
| SCHEMBL14389545 | 1.00 | ALDH1A1 (0.32) | ALDH1A1TDP1RECQLGLAHPGD | |
| SCHEMBL13350293 | 1.00 | ALDH1A1 (0.32) | ALDH1A1TDP1RECQLGLAHPGD | |
| SCHEMBL13840657 | 0.93 | ALDH1A1 (0.35) | ALDH1A1TDP1RECQLGLAHPGD | |
| SCHEMBL18770958 | 0.93 | ALDH1A1 (0.35) | ALDH1A1TDP1RECQLGLAHPGD | |
| SCHEMBL9008193 | 0.93 | ALDH1A1 (0.35) | ALDH1A1TDP1RECQLGLAHPGD | |
| SCHEMBL86221 | 0.93 | ALDH1A1 (0.35) | ALDH1A1TDP1RECQLGLAHPGD | |
| SCHEMBL9008349 | 0.93 | ALDH1A1 (0.35) | ALDH1A1TDP1RECQLGLAHPGD | |
| SCHEMBL311594 | 0.93 | ALDH1A1 (0.35) | ALDH1A1TDP1RECQLGLAHPGD | |
| SCHEMBL17364481 | 0.87 | ALDH1A1 (0.32) | ALDH1A1TDP1RECQLGLAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230241675-A1 | COMPOSITIONS, COMPRISING PLATELET-SHAPED TRANSITION METAL PARTICLES | BASF SE (DE) | 2023-08-03 | — | — | US | disclosed |
| US-20230203274-A1 | ADDITIVE COMPOSITION AND USE THEREOF, CONDENSATION POLYMER COMPOSITION,MOLDING COMPOUND AND MOLDING COMPOUNDS PRODUCED THEREFROM, AND MOLDED PARTS AND USE THEREOF | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2023-06-29 | — | — | US | disclosed |
| US-20180222087-A1 | ENCAPSULATED STABILIZER COMPOSITIONS | CYTEC INDUSTRIES INC. | 2018-08-09 | — | — | US | disclosed |
| US-20130165558-A1 | LAYERED SILICATE FLAME RETARDANT COMPOSITIONS | BASF SE (DE) | 2013-06-27 | — | — | US | disclosed |
| US-8461235-B2 | Use of polymer powder containing UV absorber for the stabilisation of polymers against the effects of UV radiation | BASF SE (DE) | 2013-06-11 | — | — | US | disclosed |
| US-8415414-B2 | Polyurethane flame retardant compositions | BASF SE (DE) | 2013-04-09 | — | — | US | disclosed |
| US-20120146257-A1 | PROCESSING ADDITIVES AND USES OF SAME IN ROTATIONAL MOLDING | CYTEC TECHNOLOGY CORP. (US) | 2012-06-14 | — | — | US | disclosed |
| US-20120088867-A1 | PERMANENT ANTISTATIC ADDITIVE COMPOSITION | BASF SE (DE) | 2012-04-12 | — | — | US | disclosed |
| US-20110269880-A1 | LAYERED SILICATE FLAME RETARDANT COMPOSITIONS | BASF SE (DE) | 2011-11-03 | — | — | US | disclosed |
| US-20110230604-A1 | Polyurethane Flame Retardant Compositions | BASF SE (DE) | 2011-09-22 | — | — | US | disclosed |
| US-7786199-B2 | Flame-retardants | CIBA SPECIALTY CHEMICALS CORP. (US) | 2010-08-31 | — | — | US | disclosed |
| US-20100190929-A1 | USE OF POLYMER POWDER CONTAINING UV ABSORBER FOR THE STABILISATION OF POLYMERS AGAINST THE EFFECTS OF UV RADIATION | BASF AKTIENGESELLSCHAFT (DE) | 2010-07-29 | — | — | US | disclosed |
| US-7728057-B2 | Use of polymer powder containing UV absorber for the stabilisation of polymers against the effects of UV radiation | BASF AKTIENGESELLSCHAFT (DE) | 2010-06-01 | — | — | US | disclosed |
| US-7645851-B2 | Polycarbonate with reduced color | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2010-01-12 | — | — | US | disclosed |
| US-7541420-B2 | Method for making molded polycarbonate articles with improved color | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2009-06-02 | — | — | US | disclosed |
| US-20080269383-A1 | Flame-Retardants | CIBA SPECIALTY CEMICALS HOLDING INC. (CH) | 2008-10-30 | — | — | US | disclosed |
| US-20080004379-A1 | Polycarbonate with Reduced Color | GENERAL ELECTRIC COMPANY (US) | 2008-01-03 | — | — | US | disclosed |
| US-20080004407-A1 | Molding polycarbonate resin made by a transesterification reaction using an activated diaryl carbonate such that the polycarbonate is susceptible to formation of internal ester linkages (IEL), and controlling (IEL) through incorporation of phosphite additive that inhibits the linkages | GENERAL ELECTRIC COMPANY (US) | 2008-01-03 | — | — | US | disclosed |
| EP-1404729-B1 | METHOD OF GRAFTING ETHYLENICALLY UNSATURATED CARBOXYLIC ACID DERIVATIVES ONTO THERMOPLASTIC POLYMERS USING HYDROXYLAMINE ESTERS | CIBA SC HOLDING AG (CH) | 2007-11-21 | — | — | EP | disclosed |
| US-20070170398-A1 | Polypropylene resin compositions | SCHMIDT HANS-WERNER | 2007-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088867-A1 | PERMANENT ANTISTATIC ADDITIVE COMPOSITION | PHOSPHO1, HCN3, SMURF1 | ALDH1A1 3486/4885TDP1 1414/4885RECQL 3628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.